Research will focus on the brain’s reward pathways that respond to opioids.
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 for research on dopamine’s role in Alzheimer’s disease.
For years, the terms “Alzheimer’s” and “dementia” have been used interchangeably. But the difference between them is important.
OMRF awarded scientific prizes to four scientists and honored a board member on Tuesday at its spring board meeting.
Alzheimer’s affects 5.8 million Americans, and one in three senior citizens dies with the disease or other forms of dementia.
Dopamine is a chemical responsible for voluntary movement and the perception of rewards in the brain.